|
|
|
|
| LEADER |
02562nam a2200349 4500 |
| 001 |
ocn647691979 |
| 003 |
OCoLC |
| 005 |
20180501121929.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
080801s2007 nyua o 001 0 eng d |
| 040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d UBY
|d OCLCQ
|d OPELS
|d OCLCQ
|d GrThAP
|
| 019 |
|
|
|a 505139280
|
| 020 |
|
|
|a 012260833X
|q (electronic bk.)
|
| 020 |
|
|
|a 9780122608339
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)647691979
|z (OCoLC)505139280
|
| 050 |
|
4 |
|a RS189
|b .P7633 2007eb
|
| 082 |
0 |
4 |
|a 615.1/901
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Profiles of drug substances, excipients, and related methodology.
|n Volume 33 /
|c edited by Harry G. Brittain.
|
| 260 |
|
|
|a New York :
|b Elsevier/Academic Press,
|c 2007.
|
| 300 |
|
|
|a 1 online resource (xiv, 726 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 520 |
|
|
|a Whilst following in the footsteps of previous volumes by presenting comprehensive reviews of drug substances and additional materials, this title also heralds a significant expansion of the scope of the series. Traditional contributions will now also be augmented by publication of critical review chapters that summarize information related to the characterization of drug substances and excipients. This change is required to better meet the needs of the pharmaceutical communtiy and to allow the development of a timely vehicle for publishing review materials on this topic. The scope of the Profiles series will encompass review articles and database compilations that fall within one of the following six broad categories: Physical profiles of drug substances and excipients; Analytical profiles of drug substances and excipients; Drug metabolism and pharmacokinetic profiles of drug substances and excipients; Methodology related to the characterization of drug substances and excipients; Methods of chemical synthesis; and Reviews of the uses and applications for individual drug substances, classes of drug substances, or excipients. * Presents comprehensive reviews covering all aspects of drug development and formulation of drugs * Now encompassing critical review chapters * Meets the information needs of the drug development community.
|
| 650 |
|
0 |
|a Drugs
|x Analysis.
|
| 650 |
|
0 |
|a Excipients
|x Analysis.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Brittain, H. G.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/18715125/33
|z Full Text via HEAL-Link
|
